{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:27:52Z","timestamp":1792787272463,"version":"4.5.0"},"reference-count":27,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"unspecified","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Sichuan Province Clinical Key Specialty Construction Project"},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2023YFS0044"],"award-info":[{"award-number":["2023YFS0044"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC0752"],"award-info":[{"award-number":["2024NSFSC0752"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024YFHZ0322"],"award-info":[{"award-number":["2024YFHZ0322"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472663"],"award-info":[{"award-number":["82472663"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,5,18]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Oesophageal squamous cell carcinoma (ESCC) is a globally challenging digestive tract malignancy with poor prognosis and limited treatment options. Early-stage ESCC is often asymptomatic, leading to a late-stage diagnosis in many cases. Neoadjuvant therapy combined with surgery is the standard treatment approach for locally advanced ESCC. In recent years, immunotherapy has shown significant efficacy in ESCC. However, various neoadjuvant treatment regimens, including chemotherapy, radiotherapy and immunotherapy, have produced inconsistent outcomes. This study aims to evaluate the efficacy and safety of neoadjuvant chemotherapy (nCT) or neoadjuvant chemoradiotherapy (nCRT) combined with immunotherapy compared with nCRT alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a prospective, multicentre, randomised, controlled phase III trial enrolling 420 patients with locally advanced thoracic ESCC. Patients will be randomly assigned (1:1:1) into three groups: (A) nCT plus sintilimab, (B) nCRT plus sintilimab or (C) nCRT alone. The primary endpoints are pathological complete response and event-free survival. Secondary endpoints include the objective remission rate, disease control rate, R0 resection rate, major pathological remission rate, disease-free survival, overall survival, patient quality of life and patient-reported outcomes. Data will be analysed using both the intention-to-treat and per-protocol approaches, with multiple imputation methods for handling missing data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study has been approved by the Ethics Committee for Medical Research and New Medical Technology of Sichuan Cancer Hospital (approval number: SCCHEC-02-2022-108). Written informed consent will be obtained from all participants. The findings will be disseminated through peer-reviewed journals and conference presentations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05244798\">NCT05244798<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-095828","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:25:36Z","timestamp":1749050736000},"page":"e095828","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Neoadjuvant chemotherapy or chemoradiotherapy plus sintilimab versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a study protocol of a multicentre, randomised, controlled, phase III trial (SCIENCE study)"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05244798","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2477-9587","authenticated-orcid":false,"given":"Wenwu","family":"He","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansong","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongchen","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Leshan People's Hospital, Leshan, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Suining Central Hospital, Suining, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangning","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiang","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haomiao","family":"Qing","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungchang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5897-0419","authenticated-orcid":false,"given":"Xuefeng","family":"Leng","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"2025121602105245000_15.6.e095828.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2025121602105245000_15.6.e095828.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338"},{"key":"2025121602105245000_15.6.e095828.3","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2016.0093"},{"key":"2025121602105245000_15.6.e095828.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70142-5"},{"key":"2025121602105245000_15.6.e095828.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112088"},{"key":"2025121602105245000_15.6.e095828.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.1483"},{"key":"2025121602105245000_15.6.e095828.7","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.03614"},{"key":"2025121602105245000_15.6.e095828.8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","article-title":"Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: The NEOCRTEC5010 randomized clinical trial","volume":"156","author":"Yang","year":"2021","journal-title":"JAMA Surg"},{"key":"2025121602105245000_15.6.e095828.9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamaoncol.2018.5441","article-title":"Efficacy and safety of pembrolizumab for heavily pretreated patients with advanced, metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: the phase 2 KEYNOTE-180 study","volume":"5","author":"Shah","year":"2019","journal-title":"JAMA Oncol"},{"key":"2025121602105245000_15.6.e095828.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01888"},{"key":"2025121602105245000_15.6.e095828.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10388-021-00850-0"},{"key":"2025121602105245000_15.6.e095828.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30626-6"},{"key":"2025121602105245000_15.6.e095828.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032125"},{"key":"2025121602105245000_15.6.e095828.14","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/oncolo\/oyab011","article-title":"Toripalimab plus paclitaxel and carboplatin as neoadjuvant therapy in locally advanced resectable esophageal squamous cell carcinoma","volume":"27","author":"He","year":"2022","journal-title":"Oncologist"},{"key":"2025121602105245000_15.6.e095828.15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1118902","article-title":"The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis","volume":"14","author":"He","year":"2023","journal-title":"Front Immunol"},{"key":"2025121602105245000_15.6.e095828.16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejca.2020.11.039","article-title":"Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1)","volume":"144","author":"Li","year":"2021","journal-title":"Eur J Cancer"},{"key":"2025121602105245000_15.6.e095828.17","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388"},{"key":"2025121602105245000_15.6.e095828.18","first-page":"212","article-title":"Cancer statistics in China, 2016","volume":"45","author":"Zheng","year":"2023","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"2025121602105245000_15.6.e095828.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097225","article-title":"Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"key":"2025121602105245000_15.6.e095828.20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01541.x"},{"key":"2025121602105245000_15.6.e095828.21","doi-asserted-by":"crossref","first-page":"1041233","DOI":"10.3389\/fimmu.2022.1041233","article-title":"Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"2025121602105245000_15.6.e095828.22","doi-asserted-by":"crossref","first-page":"974684","DOI":"10.3389\/fonc.2022.974684","article-title":"Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"2025121602105245000_15.6.e095828.23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1117448"},{"key":"2025121602105245000_15.6.e095828.24","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-023-07534-3","article-title":"Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol","volume":"24","author":"Chen","year":"2023","journal-title":"Trials"},{"key":"2025121602105245000_15.6.e095828.25","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-10687-8","article-title":"Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Cancer"},{"key":"2025121602105245000_15.6.e095828.26","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.917961","article-title":"Neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed: the study protocol for the randomized controlled NEEDS trial","volume":"12","author":"Nilsson","year":"2022","journal-title":"Front Oncol"},{"key":"2025121602105245000_15.6.e095828.27","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07387-y","article-title":"A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol","volume":"20","author":"Gao","year":"2020","journal-title":"BMC Cancer"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-095828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T10:12:30Z","timestamp":1765879950000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-095828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,4]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjopen-2024-095828"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-095828","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}